PCS-2023 > 3 > 3E > 3E0 > 3E0B |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0B | Introduction, Ear | |
3E0B3 | Percutaneous | |
3E0B30 | Antineoplastic | |
3E0B304 | Introduction of Liquid Brachytherapy Radioisotope into Ear, Percutaneous Approach | |
3E0B305 | Introduction of Other Antineoplastic into Ear, Percutaneous Approach | |
3E0B30M | Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach | |
3E0B32 | Anti-infective | |
3E0B328 | Introduction of Oxazolidinones into Ear, Percutaneous Approach | |
3E0B329 | Introduction of Other Anti-infective into Ear, Percutaneous Approach | |
3E0B33 | Anti-inflammatory | |
3E0B33Z | Introduction of Anti-inflammatory into Ear, Percutaneous Approach | |
3E0B3B | Anesthetic Agent | |
3E0B3BZ | Introduction of Anesthetic Agent into Ear, Percutaneous Approach | |
3E0B3H | Radioactive Substance | |
3E0B3HZ | Introduction of Radioactive Substance into Ear, Percutaneous Approach | |
3E0B3K | Other Diagnostic Substance | |
3E0B3KZ | Introduction of Other Diagnostic Substance into Ear, Percutaneous Approach | |
3E0B3N | Analgesics, Hypnotics, Sedatives | |
3E0B3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Ear, Percutaneous Approach | |
3E0B3T | Destructive Agent | |
3E0B3TZ | Introduction of Destructive Agent into Ear, Percutaneous Approach | |
3E0B3G | Other Therapeutic Substance | |
3E0B3GC | Introduction of Other Therapeutic Substance into Ear, Percutaneous Approach | |
3E0B7 | Via Natural or Artificial Opening | |
3E0B70 | Antineoplastic | |
3E0B704 | Introduction of Liquid Brachytherapy Radioisotope into Ear, Via Natural or Artificial Opening | |
3E0B705 | Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening | |
3E0B70M | Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening | |
3E0B72 | Anti-infective | |
3E0B728 | Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening | |
3E0B729 | Introduction of Other Anti-infective into Ear, Via Natural or Artificial Opening | |
3E0B73 | Anti-inflammatory | |
3E0B73Z | Introduction of Anti-inflammatory into Ear, Via Natural or Artificial Opening | |
3E0B7B | Anesthetic Agent | |
3E0B7BZ | Introduction of Anesthetic Agent into Ear, Via Natural or Artificial Opening | |
3E0B7H | Radioactive Substance | |
3E0B7HZ | Introduction of Radioactive Substance into Ear, Via Natural or Artificial Opening | |
3E0B7K | Other Diagnostic Substance | |
3E0B7KZ | Introduction of Other Diagnostic Substance into Ear, Via Natural or Artificial Opening | |
3E0B7N | Analgesics, Hypnotics, Sedatives | |
3E0B7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Ear, Via Natural or Artificial Opening | |
3E0B7T | Destructive Agent | |
3E0B7TZ | Introduction of Destructive Agent into Ear, Via Natural or Artificial Opening | |
3E0B7G | Other Therapeutic Substance | |
3E0B7GC | Introduction of Other Therapeutic Substance into Ear, Via Natural or Artificial Opening | |
3E0BX | External | |
3E0BX0 | Antineoplastic | |
3E0BX04 | Introduction of Liquid Brachytherapy Radioisotope into Ear, External Approach | |
3E0BX05 | Introduction of Other Antineoplastic into Ear, External Approach | |
3E0BX0M | Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach | |
3E0BX2 | Anti-infective | |
3E0BX28 | Introduction of Oxazolidinones into Ear, External Approach | |
3E0BX29 | Introduction of Other Anti-infective into Ear, External Approach | |
3E0BX3 | Anti-inflammatory | |
3E0BX3Z | Introduction of Anti-inflammatory into Ear, External Approach | |
3E0BXB | Anesthetic Agent | |
3E0BXBZ | Introduction of Anesthetic Agent into Ear, External Approach | |
3E0BXH | Radioactive Substance | |
3E0BXHZ | Introduction of Radioactive Substance into Ear, External Approach | |
3E0BXK | Other Diagnostic Substance | |
3E0BXKZ | Introduction of Other Diagnostic Substance into Ear, External Approach | |
3E0BXN | Analgesics, Hypnotics, Sedatives | |
3E0BXNZ | Introduction of Analgesics, Hypnotics, Sedatives into Ear, External Approach | |
3E0BXT | Destructive Agent | |
3E0BXTZ | Introduction of Destructive Agent into Ear, External Approach | |
3E0BXG | Other Therapeutic Substance | |
3E0BXGC | Introduction of Other Therapeutic Substance into Ear, External Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |